Disease-modifying therapies for multiple sclerosis

What you need to know: Disease-modifying therapies (DMTs) early in the course of active relapsing multiple sclerosis can prevent relapses, new brain and spinal cord lesions, and worsening neurological disability; Some DMTs are associated with potentially serious adverse reactions, and careful monito...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) Jg. 363; S. k4674
Hauptverfasser:	De Angelis, Floriana, John, Nevin A, Brownlee, Wallace J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England BMJ Publishing Group LTD 27.11.2018
Schlagworte:	Blood pressure Case reports Clinical decision making Clinical trials Copolymer 1 Cost analysis Creatinine Decision making Drug dosages Drug therapy Echocardiography EKG Evidence-based medicine Hepatitis B HIV Human immunodeficiency virus Injection Interferon Leukoencephalopathy Magnetic resonance imaging Monoclonal antibodies Multiple sclerosis Neurology Patient care planning Progressive multifocal leukoencephalopathy Thrombocytopenic purpura Thyroid Tuberculosis Urea Varicella United Kingdom > UK
ISSN:	0959-8138, 1756-1833, 1756-1833
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!